Your browser doesn't support javascript.
loading
Inhibition of CKLF1 ameliorates hepatic ischemia-reperfusion injury via MAPK pathway.
Li, Fang-Fang; Zhou, Xin; Chu, Shi-Feng; Chen, Nai-Hong.
Affiliation
  • Li FF; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica & Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Zhou X; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica & Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Chu SF; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica & Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Chen NH; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica & Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China; College of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hu
Cytokine ; 141: 155429, 2021 05.
Article in En | MEDLINE | ID: mdl-33578361
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Peptides / Reperfusion Injury / Chemokines / MAP Kinase Signaling System / MARVEL Domain-Containing Proteins / Liver / Liver Diseases Limits: Animals Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Peptides / Reperfusion Injury / Chemokines / MAP Kinase Signaling System / MARVEL Domain-Containing Proteins / Liver / Liver Diseases Limits: Animals Language: En Year: 2021 Type: Article